Skip to main content
HR 5423 115th Congress House Health Advisory bodies Digestive and metabolic diseases Health information and medical records Health programs administration and funding Health promotion and preventive care Medical research Medical tests and diagnostic methods Sex and reproductive health Women's health

GEDI Act

Introduced: April 2, 2018 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 2, 2018
Referred to the House Committee on Energy and Commerce.
Apr 2, 2018
Introduced in House
 Plain-English summary Congressional Research Service

Gestational Diabetes Act of 2018 or the GEDI Act

This bill amends the Public Health Service Act to direct the Centers for Disease Control and Prevention (CDC) to develop a multisite gestational diabetes research project to expand and enhance surveillance data and public health research on gestational diabetes. 

The CDC must expand and intensify public health research on gestational diabetes.

The CDC must: (1) award grants for demonstration projects to reduce the incidence of gestational diabetes, the recurrence of such disease in subsequent pregnancies, and the development of type 2 diabetes in women with a history of gestational diabetes; and (2) work with state and Indian tribal-based diabetes prevention and control programs assisted by the CDC to encourage postpartum follow-up after gestational diabetes to reduce the incidence of gestational diabetes and its recurrence, the development of type 2 diabetes in at-risk women, and related complications.

What's happening now April 2, 2018

Referred to the House Committee on Energy and Commerce.

 Committees of jurisdiction 1
 Cosponsors 2
All 2 Democratic 2